One-Time gene therapy could change pompe disease treatment
NCT ID NCT07282847
First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times
Summary
This study tests a single intravenous dose of a gene therapy called AB-1009 in 12 adults with late-onset Pompe disease. Participants must have been on enzyme replacement therapy for at least 6 months. The main goal is to check safety and side effects, while also seeing if the treatment helps control the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOPD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barrow Neurological Institute
NOT_YET_RECRUITINGPhoenix, Arizona, 85013, United States
-
Duke University
RECRUITINGDurham, North Carolina, 27705, United States
-
Hospital of the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
NYU Langone
NOT_YET_RECRUITINGNew York, New York, 10016, United States
-
Stanford Neuroscience Health Center
NOT_YET_RECRUITINGPalo Alto, California, 94304, United States
-
University of California, Irvine (UCI)
RECRUITINGIrvine, California, 92697, United States
-
University of Pittsburgh Medical Center (UPMC)
NOT_YET_RECRUITINGPittsburgh, Pennsylvania, 15213, United States
-
University of Texas Southwest Medical Center
RECRUITINGDallas, Texas, 75235, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Virginia Commonwealth University (VCU)
NOT_YET_RECRUITINGRichmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hope for pompe patients: could a switch in enzyme therapy slow decline?
- Shocking muscles to move: new exercise hope for nerve disease patients
- New study monitors pregnancy in pompe disease patients
- New drug cocktail aims to boost walking and breathing in pompe patients
- Pompe disease study aims to clear path for gene therapy
- New study tracks early signs of pompe disease in newborns